Liothyronine Sodium Tablets
Product Description
Liothyronine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.
Pack Size
100 Tablets
Dosage
Tablets
Strength
5 mcg
NDC
70377-114-11
Liothyronine Sodium Tablets, USP 25 mcg
Product Description
Liothyronine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.
Pack Size
100 Tablets
Dosage
Tablets
Strength
25 mcg
NDC
70377-115-11
Liothyronine Sodium Tablets, USP 50 mcg
Product Description
Liothyronine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.
Pack Size
100 Tablets
Dosage
Tablets
Strength
50 mcg
NDC
70377-116-11
E.E.S. (Erythromycin Ethylsuccinate) Film-Coated Tablets, 400 mg
Product Description
Erythromycin is used to prevent and treat infections. The product will be launched on February 15th 2025.
Pack Size
30 tablets
Dosage
Tablets
Strength
400 mg
NDC
80005-161-08
Balsalazide Disodium Capsules USP, 750 mg
Product Description
Balsalazide disodium capsules are indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older.
Pack Size
280
Dosage
Capsules
Strength
750
NDC
80005-126-25
Lomustine Capsules, USP – 10 mg
Product Description
Lomustine Capsules, USP is indicated for the treatment of patients with primary and metastatic brain tumors following appropriate surgical and/or radiotherapeutic procedures. Lomustine Capsules, USP is also indicated as a component of combination chemotherapy for the treatment of patients with Hodgkin’s lymphoma whose disease has progressed following initial chemotherapy.
Pack Size
6
Dosage
Capsules
Strength
10 mg
NDC
80005-114-02
Lomustine Capsules, USP – 40 mg
Product Description
Lomustine Capsules, USP is indicated for the treatment of patients with primary and metastatic brain tumors following appropriate surgical and/or radiotherapeutic procedures. Lomustine Capsules, USP is also indicated as a component of combination chemotherapy for the treatment of patients with Hodgkin’s lymphoma whose disease has progressed following initial chemotherapy.
Pack Size
6
Dosage
Capsules
Strength
40 mg
NDC
80005-115-02
Lomustine Capsules, USP – 100 mg
Product Description
Lomustine Capsules, USP is indicated for the treatment of patients with primary and metastatic brain tumors following appropriate surgical and/or radiotherapeutic procedures. Lomustine Capsules, USP is also indicated as a component of combination chemotherapy for the treatment of patients with Hodgkin’s lymphoma whose disease has progressed following initial chemotherapy.
Pack Size
6
Dosage
Capsules
Strength
40 mg
NDC
80005-116-02
Etravirine Tablets 100mg
Product Description
Etravirine belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs). It is primarily used in the treatment of HIV-1 infection in combination with other antiretroviral agents. Etravirine works by inhibiting the reverse transcriptase enzyme, thereby reducing viral replication and slowing down the progression of HIV disease.
Pack Size
120 Tablets
Dosage
Tablets
Strength
100 MG
NDC
69315-285-20
Etravirine Tablets 200mg
Product Description
Etravirine belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs). It is primarily used in the treatment of HIV-1 infection in combination with other antiretroviral agents. Etravirine works by inhibiting the reverse transcriptase enzyme, thereby reducing viral replication and slowing down the progression of HIV disease.
Pack Size
60 Tablets
Dosage
Tablets
Strength
200mg
NDC
69315-286-06
Aminocaproic Acid Tablets, USP 500mg
Product Description
Aminocaproic Acid Tablets USP, 500 mg are essential for managing bleeding disorders associated with increased fibrinolytic activity. Their role in stabilizing clot formation makes them a critical component of treatment in surgical and clotting disorder contexts
Pack Size
30
Dosage
Tablets
Strength
500mg
NDC
70377-102-11
Aminocaproic Acid Tablets, USP 1000mg
Product Description
Aminocaproic Acid Tablets USP, 1000 mg, are essential for managing bleeding disorders associated with increased fibrinolytic activity. Their role in stabilizing clot formation makes them a critical component of treatment in surgical and clotting disorder contexts
Pack Size
30
Dosage
Tablets
Strength
100mg
NDC
70377-103-11
Primidone Tablets 50 mg
Product Description
Primidone Tablets USP, available in strengths of 50 mg and 250 mg, are important medications for the management of epilepsy and seizure disorders.
Will be launched by August 7th, 2024.
Pack Size
100 Tablets
Dosage
Tablets
Strength
50 mg
NDC
80005-117-11
Primidone Tablets 50 mg
Product Description
Primidone Tablets USP, available in strengths of 50 mg and 250 mg, are important medications for the management of epilepsy and seizure disorders.
Will be launched by August 7th, 2024.
Pack Size
500 Tablets
Dosage
Tablets
Strength
50 mg
NDC
80005-117-14
Primidone Tablets 250 mg
Product Description
Primidone Tablets USP, available in strengths of 50 mg and 250 mg, are important medications for the management of epilepsy and seizure disorders.
Will be launched by August 7th, 2024.
Pack Size
100 Tablets
Dosage
Tablets
Strength
250 mg
NDC
80005-118-11
Letrozole Tablets USP, 2.5 mg
Product Description
Letrozole Tablets USP, 2.5 mg are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
Will be launched soon.
Pack Size
30 counts
Dosage
Tablets
Strength
2.5 mg
NDC
80005-139-08
Rasagiline Tablets, 0.5 mg
Product Description
Pack Size
30 Tablets
Dosage
Tablets
Strength
0.5 mg
NDC
80005-141-08
Rasagiline Tablets, 0.5 mg
Product Description
Pack Size
90 Tablets
Dosage
Tablets
Strength
0.5 mg
NDC
80005-141-10
Rasagiline Tablets, 0.5 mg
Product Description
Pack Size
500 Tablets
Dosage
Tablets
Strength
0.5 mg
NDC
80005-141-14
Rasagiline Tablets, 0.5 mg
Product Description
Pack Size
30 Tablets
Dosage
Tablets
Strength
1 mg
NDC
80005-142-08
Rasagiline Tablets, 1 mg
Product Description
Pack Size
90 Tablets
Dosage
Tablets
Strength
1 mg
NDC
80005-142-10
Rasagiline Tablets, 1 mg
Product Description
Pack Size
500 Tablets
Dosage
Tablets
Strength
1 mg
NDC
80005-142-14
Vigabatrin 500 mg tablets, USP
Product Description
Pack Size
100 Counts, 500 mg
Dosage
Tablets
Strength
500 mg
NDC
80005-167-11
